foxo4-dri peptide senolytic skin UK | Research FOXO4-DRI: Human Trial Status, Cancer

They work primarily by enhancing the body's natural healing mechanisms, leading to faster restoration of injured tissues such as ligaments and tendons

Safety Takeaway Due to incomplete safety data, the theoretical risk of cancer acceleration, and the potential for abuse, its use must be strictly limited to controlled research settings

Statistical analysis Statistical analysis was performed using the ShapiroWilk test for distribution assessment

TB4 has been investigated for wound healing, muscle and cardiac repair, and eye injuries, though human evidence remains limited and long-term safety in humans is not well established

BPC-157 is one of the most frequently referenced peptides in preclinical models exploring tendon and ligament recovery and connective-tissue behaviour